FLT3 and acute myeloid leukemia: Mutations in the tyrosine kinase receptor Flt3, including internal tandem duplication (ITD) mutations and tyrosine kinase domain (TKD) mutations, are the most common changes in AML, which constitutively activate the Flt3 receptor [1].